Outcome of Clinical Phenotypes of Pediatric Myocarditis at Assiut University Children Hospital

Not yet recruitingOBSERVATIONAL
Enrollment

100

Participants

Timeline

Start Date

June 1, 2026

Primary Completion Date

June 1, 2027

Study Completion Date

August 1, 2027

Conditions
MyocarditisMyocarditis Acute
Interventions
OTHER

Standard Medical Therapy

All enrolled children will receive standard medical therapy tailored to clinical status. This includes inotropes (e.g., dopamine, dobutamine, milrinone), ACE inhibitors, beta-blockers, and/or diuretics as indicated. Treatment is supportive and adjusted according to severity of cardiac dysfunction and hemodynamic status. The goal is to stabilize heart failure, improve cardiac output, and prevent progression to dilated cardiomyopathy.

DRUG

Standard Medical Therapy

"All enrolled children will receive standard medical therapy tailored to clinical status. This includes inotropes (dopamine, dobutamine, milrinone), ACE inhibitors, beta-blockers, and/or diuretics as indicated. Therapy is supportive and adjusted according to severity of cardiac dysfunction and hemodynamic status to stabilize heart failure, improve cardiac output, and prevent progression to dilated cardiomyopathy.~2️⃣ Intervention 2"

All Listed Sponsors
lead

Assiut University

OTHER

NCT07175948 - Outcome of Clinical Phenotypes of Pediatric Myocarditis at Assiut University Children Hospital | Biotech Hunter | Biotech Hunter